A detailed history of Fora Capital, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Fora Capital, LLC holds 27,894 shares of SWTX stock, worth $1.04 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
27,894
Previous 23,024 21.15%
Holding current value
$1.04 Million
Previous $840,000 63.33%
% of portfolio
0.12%
Previous 0.07%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$36.5 - $52.5 $177,755 - $255,675
4,870 Added 21.15%
27,894 $1.37 Million
Q4 2023

Feb 14, 2024

BUY
$18.94 - $37.24 $436,074 - $857,413
23,024 New
23,024 $840,000
Q3 2021

Nov 15, 2021

SELL
$62.66 - $88.26 $96,872 - $136,449
-1,546 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$67.45 - $85.63 $104,277 - $132,383
1,546 New
1,546 $127 Million
Q1 2021

May 17, 2021

SELL
$65.1 - $93.59 $338,324 - $486,387
-5,197 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$48.36 - $77.92 $251,326 - $404,950
5,197 New
5,197 $376,000
Q3 2020

Nov 13, 2020

SELL
$36.14 - $51.99 $21,973 - $31,609
-608 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$22.98 - $48.57 $13,971 - $29,530
608 New
608 $26 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.33B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.